Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study.
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2014
At a glance
- Drugs Bevacizumab (Primary) ; Paclitaxel (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- Acronyms AbraxAvast
- 13 Jun 2011 Status changed from active, no longer recruiting to completed.
- 07 Jun 2011 Results were presented at the 47th Annual Meeting of the American Society of Oncology (ASCO-2011).
- 23 Jun 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.